Search Results 181-190 of 17434 for SC

  1. Publications - Stephen J. Wisniewski, M.D. - Mayo Clinic

    ... SC, Evans CH. A phase 1 clinical trial shows safe, sustained, AAV-mediated expression of IL-1Ra in the human osteoarthritic knee joint. Sci Transl Med. 2025 ...

  2. Publications - Joe Zein, M.D., Ph.D. - Mayo Clinic

    ... SC, Fahy JV, Fajt ML, Gaston BM, Jackson DJ, Jain S, Jarjour NN, Kenyon NJ ... SC, Fahy JV, Israel E, Jarjour NN, Levy B, Mauger D, Moore WC, Wenzel SE ...

  3. Digestive Diseases Clinical Trials - Medical Professionals

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  4. John M. Nathan, M.D.,D.D.S.

    John Nathan, M.D., D.D.S., M.Sc., is an oral and maxillofacial surgeon with a special interest in obstructive sleep apnea surgery, head and neck cancer and ...

  5. Risperidone (intramuscular route, subcutaneous route) - Side effects & uses - Mayo Clinic

    Risperidone injection is used to treat the symptoms of psychiatric (mental) disorders, including schizophrenia. Risperdal Consta®, Rykindo®, and Uzedy® are used ...

  6. A Study To Assess A Change In Disease Activity And Adverse Events Of Intravenous Etentamig And Daratumumab (Etentamig+D) Compared To Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible For Transplant - Mayo Clinic

    ... (SC) injections of daratumumab. Participants in phase 3 will receive RP3D doses of etentamig as IV infusions, combination with SC injections of daratumumab, or ...

  7. Publications - Roberto A. Leon-Ferre, M.D. - Mayo Clinic

    ... SC, Goetz MP, Michiels S, International Immuno-Oncology Biomarker Working Group. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. JAMA. 2024 ...

  8. Crohn's Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  9. Publications - Linda X. Yin, M.D. - Mayo Clinic

    ... SC, Price KA, McGarrah PW, Fuentes Bayne HE, Routman DM, Van Abel KM. Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer ...

  10. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

    The purpose of this study is to assess the safety of PH FDC SC when administered at home by an HHNP. Patients will be assessed for safety by regular evaluation ...